Knipp lab:Publications

From OpenWetWare

Jump to: navigation, search

Home        Contact        Internal        Lab Members        Publications        Research        Talks       

Contents

Recent Publications

  1. Summary of the national institute of child health and human development-best pharmaceuticals for children act pediatric formulation initiatives workshop-pediatric biopharmaceutics classification system working group. Abdel-Rahman SM, Amidon GL, Kaul A, Lukacova V, Vinks AA, Knipp GT. Members of the BCS Task Force. Clin Ther. 2012 Nov;34(11):S11-24. doi:10.1016/j.clinthera.2012.09.014.
  2. Comparative pharmacokinetics studies of immediate- and modified-release formulations of glipizide in pigs and dogs. Kulkarni R, Yumibe N, Wang Z, Zhang X, Tang CC, Ruterbories K, Cox A, McCain R, Knipp GT. J Pharm Sci. 2012 Nov;101(11):4327-36. doi: 10.1002/jps.23292. Epub 2012 Aug 16.
  3. The effects of intralaboratory modifications to media composition and cell source on the expression of pharmaceutically relevant transporters and metabolizing genes in the Caco-2 cell line. Roth WJ, Lindley DJ, Carl SM, Knipp GT. J Pharm Sci. 2012 Oct;101(10):3962-78. doi: 10.1002/jps.23241. Epub 2012 Jul 11.
  4. Plasma Cortisol and Noradrenalin Concentrations in Pigs: Automated Sampling of Freely Moving Pigs Housed in the PigTurn® Versus Manually Sampled and Restrained Pigs. Marchant-Forde JN, Matthews DL, Poletto R, McCain RR, Mann DD, Degraw, RT, Hampsch JM, Peters S, Knipp GT, Kissinger CB. Anim. Welfare. 2012 May; 21(2):197-205(9).
  5. The effects of media on pharmaceutically relevant transporters in the human HT-29 adenocarcinoma cell line: does culture media need to be controlled? Lindley DJ, Roth WJ, Carl SM, Knipp GT. J Pharm Sci. 2012 Apr;101(4):1616-30. doi: 10.1002/jps.23036. Epub 2011 Dec 28.
  6. Assessing the performance of amorphous solid dispersions. Newman A, Knipp G, Zografi G. J Pharm Sci. 2012 Apr;101(4):1355-77. doi: 10.1002/jps.23031. Epub 2011 Dec 27. [Editors’ Picks and Top Ten Most Downloaded Article from June 2012-Sept 2012 on the J Pharm Sci website.]
  7. Editorial: Perspectives on Pediatric Drug Development. Roth WJ, Sage DP, Kulczar C, Liu W, Knipp GT. Revista Mexicana De Ciencias Farmaceuticas 2012 43(3):5-6.
  8. The Evaluation of Peptide/Histidine Transporter 1 (PHT1) Function: Uptake Kinetics Utilizing a COS-7 Stably Transfected Cell Line. Lindley DJ, Carl SM, Mowery S, Knipp GT. Revista Mexicana De Ciencia Farmaceuticas. Octubre-Diciembre 2011; 42(4);57-65.
  9. ABC and SLC transporter expression and pot substrate characterization across the human CMEC/D3 blood-brain barrier cell line. Carl SM, Lindley DJ, Couraud PO, Weksler BB, Romero I, Mowery SA, Knipp GT. Mol Pharm. 2010 Aug 2;7(4):1057-68.
  10. Endocrine disruptors and human health. Latini G,. Knipp G, Mantovani A, Marcovecchio ML, Chiarelli F, Soder O. Mini-Rev. Med. Chem. 2010 Aug;10(9):846-55.
  11. The effects of excipients on transporter mediated absorption. Goole J, Lindley DJ, Roth W, Carl SM, Amighi K, Kauffmann JM, Knipp GT. Int J Pharm. 2010 Jun 30;393(1-2):17-31. Epub 2010 Apr 24.
  12. Maternal di-(2-ethylhexyl)-phthalate exposure influences essential fatty acid homeostasis in rat placenta. Xu Y, Agarwal S, Cook TJ, and Knipp GT. Placenta 2008 Nov;29(11):962-9. doi: 10.1016/j.placenta.2008.08.011. Epub 2008 Sep 30.

Book Chapters

Invited Chapter:

  1. D.J. Lindley, S.M. Carl, D.R. Herrera-Ruiz, L.-F. Pan, L.B. Ward, J.M.E. Goole, O.S. Gudmundsson, and G.T. Knipp. Chapter 18: Drug Transporters and Their Role in Absorption and Disposition of Peptides and Peptide Based Pharmaceuticals. In Oral Bioavailability: Basic Principles, Advanced Concepts and Application. Eds. M. Hu and X. Li. In the Wiley Series on Drug Discovery and Development, Series Ed. B. Wang, John Wiley & Sons, New York, NY. pp. 291-308 (2011).
  2. S.M. Carl, D.J. Lindley, G.T. Knipp, K.R. Morris, E. Oliver, G.W. Becker and R.A. Arnold. Biotechnology Drug Product Development. In Pharmaceutical Manufacturing Handbook, Editor S.H. Gad, John Wiley & Sons, New York, NY, pp. 1-32 (2008). [DOI: 10.1002/9780470259818.ch1; Republished in a Wiley Special Edition Series “Pharmaceutical Sciences Encyclopedia: Drug Discovery, Development, and Manufacturing.” DOI: 10.1002/9780470571224.pse340 1-26 (2010)].
  3. E. Oliver, S.M. Carl, K.R. Morris, G.W. Becker and G.T. Knipp. Regulatory Considerations in the Approval of Follow-On Protein Drug Products. In Pharmaceutical Manufacturing Handbook, Editor S.H. Gad, John Wiley & Sons, New York, NY, pp. 33-57 (2008). [DOI: 10.1002/9780470259818.ch2; Republished in a Wiley Special Edition Series entitled “Pharmaceutical Sciences Encyclopedia: Drug Discovery, Development, and Manufacturing.” 1–32 (2010)].
  4. S.M. Carl, D.J. Lindley, G.T. Knipp, K.R. Morris, E. Oliver, G.W. Becker and R.A. Arnold, Biotechnology Drug Product Development. In Pharmaceutical Manufacturing Handbook, Editor S.H. Gad, John Wiley & Sons, New York, NY, pp. 1-32 (2008).
  5. E. Oliver, S.M. Carl, K.R. Morris, G.W. Becker and G.T. Knipp. Regulatory Considerations in the Approval of Follow On Protein Drug Products. In Pharmaceutical Manufacturing Handbook, Editor S.H. Gad, John Wiley & Sons, New York, NY, pp. 33-57 (2008).
  6. R.K. Bhardwaj, D.R. Herrera-Ruiz, Y. Xu, S.M. Carl, T.J. Cook, N. Vorsa, and G.T. Knipp. Chapter 7: Intestinal Transporters in Drug Absorption. In Biopharmaceutics Applications in Drug Development. Editors R. Krishna and L. Yu, Kluwer Press, NY, pp. 175-261 (2008).
  7. S.M. Carl, D.R. Herrera-Ruiz, R.K. Bhardwaj, O.S. Gudmundsson, and G.T. Knipp. Chapter 6: Mammalian Oligopeptide Transporters. In Drug Transporters: Molecular Characterization and Role in Drug Disposition. Editors G. You and M. Morris. John Wiley & Sons, New York, NY. pp. 105-146 (2007).

Edited Textbook Chapters

Martin’s Physical Pharmacy and Pharmaceutical Sciences, Fifth Edition. Editor Patrick J. Sinko. Lippincott, Williams & Wilkins, Baltimore, MD, (2006).

  1. G.T. Knipp and K.R. Morris, Chapter 2: States of Matter.
  2. H. Morelos, D. Herrera-Ruiz, and G.T. Knipp, Chapter 3: Thermodynamics.
  3. G.T. Knipp, H. Morelos and D. Herrera-Ruiz, Chapter 4: Physical Properties of Drug Molecules.

Refereed Abstracts

  1. N. Yumibe, R. Kulkarni, Z. Wang, X. Zhang, K. Ruterbories, A. Cox, R. Ajamie, C.C. Tang, G. Knipp, Robin McCain. Comparative Pharmacokinetic Studies of Immediate and Modified Release Formulations of Glipizide in Pigs and Dogs. 2011 AAPS Indiana/Ohio Discussion Group-Pharma Industry Challenges/Perspectives Symposium, Indianapolis, IN (2011).
  2. W.J. Roth, C.B. Kissinger, S. Hannou, B.R. Cooper, R.R. McCain, R. Vreeman, and G.T. Knipp. Development and Testing of Novel Pediatric Formulation of Rifampicin for the Treatment of Tuberculosis (TB) in Infants and Young Children. 2011 AAPS Indiana/Ohio Discussion Group-Pharma Industry Challenges/Perspectives Symposium, Indianapolis, IN (2011). Best Poster Award.
  3. L.B. Karpes and G.T. Knipp. Characterization of the Different Permeation Pathways for Essential Fatty Acids across the Human Immortalized Blood Brain Barrier Cell Line, hCMEC/D3. 2010 American Association of Pharmaceutical Scientists Annual Meeting, New Orleans, LA. The AAPS Journal, 12(Suppl 2), Abstract M1165 (2010).
  4. W.J. Roth, D.J. Lindley, S.M Carl, and G.T. Knipp. Evaluating Culture Conditions on Cell Growth and Differentiation Characteristics in the Human Adenocarcinoma Caco-2 Cell Line. 2010 American Association of Pharmaceutical Scientists Annual Meeting, New Orleans, LA. The AAPS Journal, 12(Suppl 2), Abstract M1214 (2010).
  5. W.J. Roth, C.B. Kissinger, R. Vreeman, S. Hannou, B.R. Cooper, R.R. McCain, and G.T. Knipp. Development of a Novel Pediatric Formulation of Rifampicin for the Treatment of Tuberculosis (TB) in Infants and Young Children. 2010 American Association of Pharmaceutical Scientists Annual Meeting, New Orleans, LA. The AAPS Journal, 12(Suppl 2), Abstract M1109 (2010).
  6. S.A. Mowery, S.M Carl, D.J. Lindley, and G.T. Knipp. Membrane Expression, Localization, and Functional Analysis of Human Peptide/Histidine Transporter 1 in Gastrointestinal and BBB Cell Lines. 2010 American Association of Pharmaceutical Scientists Annual Meeting, New Orleans, LA. The AAPS Journal, 12(Suppl 2), Abstract M1205 (2010).
  7. L.F. Pan and G.T. Knipp. Delineating Potential Effects of Bisphenol A on Placental Fatty Acid Homeostasis. 2010 American Association of Pharmaceutical Scientists Annual Meeting, New Orleans, LA. The AAPS Journal, 12(Suppl 2), Abstract T3384 (2010).

Posters

  1. C.D. Kulczar, W.J. Roth, C.B. Kissinger, B.R. Cooper, R.R. McCain, R.C. Vreeman, and G.T. Knipp. "Juvenile Pigs as Surrogates for Human Pediatrics During Preclinical Pharmacokinetic Testing: A Possible Means to Expedite Pediatric Drug Development?" 2012 Pharmaceutical Graduate Student Research Meeting, Hosted by the University of Nebraska Medical Center, Omaha, NE. Best Poster Award.
  2. W.J. Roth, C.B. Kissinger, B.R. Cooper, R.R. McCain, J.N. Marchant-Forde, R.C. Vreeman, S. Hannou, and G.T. Knipp. Assessment of Juvenile Pigs to Serve as Human Pediatric Surrogates for Preclinical Formulation Pharmacokinetic Testing. 9th Biennial Globalization of Pharmacy Education Network (GPEN) Meeting. Organized by Monash University, Melbourne, Australia (2012). [Podium Presentation]
  3. W.J. Roth, C.B. Kissinger, S. Hannou, B.R. Cooper, R.R. McCain, R. Vreeman, and G.T. Knipp. Development and Testing of Novel Pediatric Formulation The 9th Annual Garnet E. Peck Symposium: Pharmaceutical Solids, Purdue University, West Lafayette, IN, October (2011).
  4. W.J. Roth, C.B. Kissinger, R. Vreeman, S. Hannou, B.R. Cooper, R.R. McCain, and G.T. Knipp. Development of a Novel Pediatric Formulation of Rifampicin for the Treatment of Tuberculosis (TB) in Infants and Young Children. 2011 Indiana CTSI Annual Meeting, Indianapolis, IN. (2011).
  5. W.J. Roth, C.B. Kissinger, R. Vreeman, S. Hannou, B.R. Cooper, R.R. McCain, and G.T. Knipp. Development of a Novel Pediatric Formulation of Rifampicin for the Treatment of Tuberculosis (TB) in Infants and Young Children. 2010 Indiana CTSI Retreat at Purdue Meeting, West Lafayette, IN. (2010).
  6. S.A. Mowery, S.M Carl, D.J. Lindley, and G.T. Knipp. Membrane Expression, Localization, and Functional Analysis of Human Peptide/Histidine Transporter 1 in Gastrointestinal and BBB Cell Lines. 8th Biennial Globalization of Pharmacy Education Network (GPEN) Meeting. Organized by the University of North Carolina, Chapel Hill, NC (2010).
  7. L.F. Pan and G.T. Knipp. Delineating Potential Effects of Bisphenol A on Placental Fatty Acid Homeostasis. 8th Biennial Globalization of Pharmacy Education Network (GPEN) Meeting. Organized by the University of North Carolina, Chapel Hill, NC (2010). [Podium Presentation]
  8. S. Hannou, G.T. Knipp, R. Pinal, R. McCain, K. Boksa, and B. Cooper. Automated Blood Sampling in the Porcine Model, A Clinically Relevant Model for Assessing the Effects of Process Variation in the Pharmacokinetics of Rifampicin. The 8th Annual Garnet Peck Symposium: Pediatric Drug Formulation and Nanotechnology in Drug Delivery, Purdue University, West Lafayette, IN, October (2010).
  9. W. Roth, S. Mowery, R. McCain, T.R. DeGraw, C. Kissinger, J. Marchant-Forde, R. Pinal, and G.T. Knipp. Relative In Vivo Exposure Comparisons of Acetaminophen from Different Sourced Capsules Utilizing the PigTurn-Culex-L System. May 2010 Dane O. Kildsig Center of Pharmaceutical Processing Research Meeting, University of Puerto Rico-San Juan, San Juan, PR, May (2010).

Hosted by

Personal tools